SLK-Kliniken Heilbronn GmbH

At SLK-Kliniken Heilbronn GmbH, research in Hemic and Lymphatic Diseases focuses strongly on acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, chronic lymphocytic leukemia, multiple myeloma, and diffuse large B-cell lymphoma. These studies are designed to improve treatment effectiveness, refine risk-adapted care, and support better outcomes for both adults and children with blood cancers.

• Testing new treatment combinations for acute myeloid leukemia and related high-risk blood disorders
• Improving therapy for acute lymphoblastic leukemia in children and adolescents
• Evaluating more effective approaches for lymphoma, chronic lymphocytic leukemia, and multiple myeloma

The site’s pediatric hematology/oncology expertise supports trials that aim to make cancer treatment more precise, more effective, and better tolerated.

A major part of the trial portfolio addresses Respiratory Tract Diseases and Neoplasms, especially non-small cell lung cancer, small cell lung cancer, and other advanced thoracic cancers. The research also includes idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, chronic obstructive pulmonary disease, and bronchiectasis, with the goal of improving survival, symptom control, and long-term lung health.

• Assessing new immunotherapy and targeted approaches for non-small cell lung cancer
• Studying treatment strategies for small cell lung cancer and advanced metastatic lung disease
• Evaluating therapies that may slow or stabilize fibrotic lung disease and other chronic respiratory conditions

This research area combines cancer care with pulmonary medicine, reflecting a broad interest in both advanced tumors and chronic lung disorders.

The site conducts substantial research in Neoplasms affecting the digestive system, including gastric cancer, gastroesophageal junction adenocarcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, and biliary tract cancer. These trials often focus on improving first-line treatment, extending disease control, and identifying more effective options for advanced or metastatic disease.

• Testing new combinations for gastric and gastroesophageal junction cancers
• Evaluating treatment strategies for colorectal cancer, including postoperative and metastatic settings
• Studying novel options for pancreatic cancer and other hard-to-treat gastrointestinal tumors

The research activity in this field aims to improve both survival and disease-free outcomes in cancers with high unmet medical need.

Another important focus is Neoplasms in women’s health and urologic cancers, including breast cancer, ovarian cancer, endometrial cancer, and muscle-invasive urothelial carcinoma. The trials explore ways to improve recurrence prevention, increase response rates, and refine treatment decisions for both early-stage and advanced disease.

• Testing targeted and immunotherapy approaches in breast cancer, including hormone receptor-positive and triple-negative disease
• Studying new options for ovarian and endometrial cancers in advanced settings
• Evaluating bladder cancer treatments that may improve event-free survival and preserve bladder function

This research reflects a strong interest in personalized cancer care across several common and aggressive tumor types.

The site also participates in broader oncology research across Analytical, Diagnostic and Therapeutic Techniques and Equipment, with emphasis on precision medicine and immunotherapy. Studies include biomarker-selected and tumor-agnostic approaches for advanced solid tumors, melanoma, neoplasms by site, and rare cancers such as malignant germ cell tumours and ependymoma.

• Evaluating biomarker-driven treatments for advanced solid tumors
• Testing immunotherapy combinations in melanoma and other difficult-to-treat cancers
• Improving diagnosis and treatment planning for selected rare tumors and pediatric brain tumors

This area highlights a modern research approach that links tumor biology with more individualized treatment strategies.

In addition to cancer research, the portfolio includes trials in Cardiovascular Diseases such as atherosclerotic cardiovascular disease and heart failure. These studies are aimed at reducing major cardiovascular events, improving long-term disease management, and exploring new therapeutic options for patients with chronic heart conditions.

• Assessing therapies intended to lower risk in atherosclerotic cardiovascular disease
• Studying treatment approaches for heart failure
• Exploring preventive strategies for patients with elevated cardiovascular risk

This adds a broader internal medicine dimension to the clinical research environment at the site.